The Beauty Health Company (NASDAQ:SKIN) Q2 2021 Results Conference Call August 10, 2021 4:30 PM ET Company Participants Dawn Francfort - MD, ICR, Inc. Clint Carnell - CEO Liyuan Woo - CFO Conference Call Participants Matthew O’Brien - Piper Sandler Steph Wissink - Jefferies Linda Bolton Weiser - D.A. Davidson Kyle Rose - Canaccord Amit Hazan - Goldman Sachs Bruce Jackson - Benchmark Operator Good day and thank you for standing by. And welcome to The Beauty Health Company Second Quarter 2021 Earnings Call. A ...

Table of Contents For the transition period from to Commission file number: 001-39565 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 The Beauty Health Company For the quarter ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact Name of Registrant as Specified in Its Charter) Indicate by check mark whether the ...

The Beauty Health Company (NASDAQ:SKIN) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Dawn Francfort – Managing Director-ICR Brent Saunders – Executive Chairman Clint Carnell – Chief Executive Officer Liyuan Woo – Chief Financial Officer Conference Call Participants Operator Greetings and welcome to The Beauty Health Company’s call to discuss the HydraFacial Company’s First Quarter Results. As a reminder, this conference is being recorded. I would now like to turn the confere ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to Commission file number: 001-39565 VESPER HEALTHCARE ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 85-1908962 (State or other ju ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) For the quarter ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39565 Vesper Healthcare Acquisition Corp. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) Delaware 85-1908962 (I.R.S. Employer Identification No.) 1819 Wes ...